All times in CET.
The agenda may be subject to change.
08.00 – 09.00
Welcome and Registration
09.00 – 09.30
Keynote Remarks
Patricia Lyn McCullagh, Deputy Permanent Representative, Permanent Mission of Canada to the United Nations and other International Organisations in Geneva
H.E. Amb. Matthew Wilson, Permanent Representative of Barbados to the UN
Sir. Dr. Jeremy Farrar, Assistant Director-General for Health Promotion and Disease Prevention and Control, WHO
Theme 3: The New Global Health Financing Pact and a new Tool to guide Innovative Investment Decisions into global health & innovation in healthcare
09.30 -10.20
H20 Tour de Table: Time for a New Global Health Financing Pact – How do we Fix Global Health Financing beyond 2030?
As global health financing faces an unprecedented emergency with declining aid flows and public spending in health, and mounting debt pressures, a systematic rethink of future health financing streams is unavoidable. If, out of 177 countries around the world, 41 are expected to contract in domestic health finance and 69 low- and middle-income countries (LMICs) are projected to stagnate, investments into health must extend beyond mere emergency response. With countries taking more ownership to strengthen their local and national health systems, initiatives such as the Lusaka Agenda (launched in 2023) seem to gain more traction with a coordinated action to speed up progress towards domestically-financed health systems and universal health coverage that leaves no one behind. The panel aims to take stock of financing mechanisms within the current geopolitical changes and what it means for national and global health. The panel will assess the future role of multilateral organizations including the WHO and Multilateral Development Banks (MDBs), funding agencies and governments and discuss how to identify new opportunities for consolidation and efficiencies to promote Health4All.
Chair: Anil Soni, CEO, WHO Foundation
Dr. Kalipso Chalkidou, Director, Health Financing and Economics, WHO
Dr. Chris James, Senior Health Policy Analyst, OECD
Dr. Meshari Alwashmi, CEO and Co-Founder, AmplifAI Health
Dr. Pete Baker, Deputy Director, Global Health Policy Program, CGD
Michikazu Koshiba, Director, Advisory Services Division, KPMG
10.20 – 11.20
Panel 5: Launch of the Health Taxonomy White Paper – A New Era of Global Health Financing, why do we need a Toolkit/Benchmark to direct and guide future Health Investments?
The report “The Health Taxonomy – The Need for a Common Investment Toolkit to Scale Up Future Investments in Health” will be launched at the H20 summit. This report seeks to address a critical gap: the absence of a shared language and strategic tool to align health-related investments and principles across public and private actors. By proposing a voluntary health investment framework (i.e.“health taxonomy”), underpinned by five principles for investments, the report aims to support a coordinated approach that reflects diverse stakeholder incentives while avoiding new regulatory burdens. If recognized by leading international agencies and financial institutions and driven by real-world demand, this tool (i.e. taxonomy) can serve as a first step toward defining what sustainable finance for health means—unlocking the potential for health to become a foundational pillar of economic stability and long-term development. The recommendation from this report suggest that G20 Health and Finance Ministers should enable the G20 Sustainable Finance Working Group (SFWG) and the G20 Joint Health and Finance Working Group (G20JFHT) to discuss and agree on a 1) joint definition on what sustainable finance for health means and 2) discuss the feasibility of implementing a health taxonomy.
Presenter: Hatice Beton, Executive Director, The G20&G7 Health and Development Partnership – Presentation of Report Findings
Chair: Roberto Duran Fernandez, Associate Professor, School of Government and Public Transformation, Monterrey Institute of Technology- Confirmed
Elsa Hyland, Angel Investor
Serina Ng, Executive Head, G20 Joint Finance and Health Taskforce
Dr. Kwasi Boahene, Director Health System, PharmAccess
Dr. Agnes Soucat, Director of Health and Social Protection, Agence Française de Développement
Kay Petrisor, Head of Strategy & Business Development, WiFOR Institute
Dr. Joanna Soroka, PhD, Principal, Hitachi Ventures GmbH
11.20 – 12.05
Lunch Break
12.05 – 12.35
Fireside: The Investment Case for Noncommunicable Diseases (NCDs)
In September, at the UN High-Level Meeting (UNHLM) for Noncommunicable Diseases and Mental Health (NCDs), policymakers will discuss how to better monitor, regulate and treat the rising challenges stemming from NCDs. While foreign ministry officials in New York need to work and negotiate hand in hand with their ministries of health, finance, education at home to achieve an acceptable resolution with tangible outcomes to tackle the UN SDG Goals 3.4 on NCDs, the reality of this unstoppable endemic is concerning. As Noncommunicable diseases, including mental health and neurological conditions, (NCDs) are the leading cause of death and disability worldwide, it poses a detrimental effect on societies and economies. If the right prevention mechanisms and policies are not put in place by policy-makers and the industry, the cost to our economies will be detrimental. This is why NCDs can only be tackled with a whole of society and cross-sectorial approach. With US$2 trillion in economic losses every year due to premature mortalities, absenteeism (missing work), and presenteeism (reduced productivity at work), NCDs are not only a health matter, they impact the health of a country and economy. In the fireside, panelists will discuss the rapidly growing NCD burden and how different sectors can work more efficiently together to provide greater impact and solutions with minimal economic interventions.
Chair: Stephanie Seydoux, WHO Director-General’s Envoy for Multilateral Affairs, WHO
Alison Cox, Policy and Advocacy Director, NCD Alliance
Charles Gore, Executive Director, MPP
Patricia Pascual, Global Head of Public Affairs, Opella Healthcare
12.35 – 13.25
Panel 6: Making the Economic Case to Invest in Women’s Health to Grow Societies and Economies – Innovative Financing Models and Best Practices
Women and women and girls often are agents of change in society. Gender considerations, policies, and commitments that foster gender equality and women’s economic empowerment. should be mainstreamed into G20 and G7 discussions.Investing in women’s health drives economic growth and yields societal benefits. The development and economic performance of nations depend, in part, upon how each country protects and promotes the health of women. Yet systemic challenges remain. This panel will explore how the G20 and G7 can elevate women’s health on the global agenda and better mobilize resources. Discussions will focus on innovative financing models, including impact investing or mechanisms such as blended finance, to attract investors, scale up prevention programmes, and ensure equitable access to screening and vaccination, ultimately promoting Universal Health Coverage.
Keynote: Dr. Elvira Marasco, President, AW20, Co-Founder, Italian Delegation Women 20 (W20)
Chair: Dr. Noha Salem, Executive Director, Global Public Policy, Organon
Dr. Afua Basoah, Co-founder & General Partner, Gern Capital Group
Renuka Gadde, Senior Advisor, CHAI
Dr Pascale Allotey, Director, Department of Sexual and Reproductive Health and Research (SRH), World Health Organization, Geneva
Dr. Anouk Petersen, Co-Director of Equity & Health at the McKinsey Health Institute
Dr. May Abdel-Wahab, Head, Division of Human Health, IAEA
13.25 – 14.10
Recommendations & Break-Out Sessions
Development of Recommendations for CTA + Q&A
Guiding Questions for Assigned Groups Following Discussions on Panels and Roundtables on Day 1 and 2
14.10 – 14.25
Coffee Break
14.25 – 14.55
H20 Tour de Table: Best of G20 & G7 HDP – A reflection of nine years
The G20&G7 Health and Development Partnership was created at the request of a small number of founding members in 2017 during the G20 Presidency of Germany. Founding partners included TBAlliance, GHTC, GHIT, Unitaid, and MMV. With the first inception of a formal health ministers gathering in Germany in 2017 focusing on a first pandemic simulation exercise and the future of health financing for cross-sectorial health challenges, including AMR, the G20&G7HDP was brought to life. For the last 9 years, the G20&G7HDP has supported the G20 and G7 Presidency agendas, developed concrete initiatives with its partners and global ambassadors, and adopted an out-of-the-box thinking approach to create innovative thought leadership campaigns. This session aims to take stock of the past 9 years, assessing key moments, pitfalls and big wins. Panelists will assess how they delivered impact on the G7 and G20 till 2025. The panel will primarily celebrate partners, global ambassadors, and their contributions to a partnership that truly champions the UN SDG17 partnerships of partnerships approach.
Chair: Andrea Lucard, Global Ambassador G20&G7HDP
Harald Nusser, Global Ambassador G20&G7HDP
Willo Brock, Global Ambassador, EU Representative, CEPI
Kristie Mikus, Director, GHTC (virtual)
Greg Perry, Director General, Global Self Care Federation
14.55 – 15.25
Announcement of Call To Action 2025 Remarks
Alan Donnelly, Chairman, The G20 & G7 Health and Development Partnership (Summit Host)
Hatice Beton, Executive Director, The G20&G7Health and Development Partnership (Summit Co-Host)